Cormorant Asset Management, LP - 11 Jan 2022 Form 4 Insider Report for Vigil Neuroscience, Inc. (VIGL)

Role: Former 10% Owner
Signature: /s/ CORMORANT ASSET MANAGEMENT, LP By: Cormorant Asset Management GP, LLC, its General Partner, By: Bihua Chen, Managing Member
Issuer symbol: VIGL
Transactions as of: 11 Jan 2022
Net transactions value: $0
Form type: 4
Filing time: 13 Jan 2022, 15:06:53 UTC
Previous filing: 06 Jan 2022
Next filing: 13 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VIGL	Common Stock	Conversion of derivative security		+616,786			616,786	11 Jan 2022	See Footnotes	F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VIGL	Series B Convertible Preferred Stock	Conversion of derivative security		-616,786	-100%		0	11 Jan 2022	Common Stock	616,786		See Footnotes	F1, F2, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Cormorant Asset Management, LP is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id	Content
F1	Shares of Series B Convertible Preferred Stock were convertible at any time at the holder's election, without payment of additional consideration. Such shares had no expiration date but converted into Common Stock automatically upon the closing of the Issuer's initial public offering.
F2	Shares reported herein are held by Cormorant Global Healthcare Master Fund, LP (the "Master Fund") and Cormorant Private Healthcare Fund IV, LP ("Fund IV"). Cormorant Asset Management, LP ("Cormorant") serves as the investment manager of the Master Fund and Fund IV. Bihua Chen serves as manager of the general partner of Cormorant. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose.
F3	Represents (i) 11,163 shares held by the Master Fund and (ii) 605,623 shares held by Fund IV.
F4	The Series B Convertible Preferred Stock represented, on an as-converted basis, (i) 11,163 shares held by the Master Fund and (ii) 605,623 shares held by Fund IV.